In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
New Study Reveals that Patient Genetics Can Influence Response to Immune Checkpoint Blockade Therapy

In the largest-ever genetic analysis of people being treated with checkpoint inhibitors, Memorial Sloan Kettering researchers looked at patients who received several checkpoint inhibitors for a number of different cancers at many different hospitals. Researchers found that people who had a greater diversity and more variation in their human leukocyte antigen (HLA) genes responded much better to immunotherapy compared with those who had less diversity. For more information or to speak with an expert, contact Rebecca Williams at [email protected].
Model of a T cell receptor and an HLA-A white blood cell antigen bound to part of a virus
Q&A
Study Uncovers Genetic Reasons Why Some People Respond to Immunotherapy Better than Others

Immunotherapy drugs called checkpoint inhibitors have been a game changer for some people with cancer. But for most patients, these drugs have been disappointing. Researchers are trying to figure out why.
medical oncologist Larry Norton
Q&A
Definitive Proof that Dose-Dense Chemotherapy Is Safe and Effective for Breast Cancer

Dose-dense chemotherapy calls for less time between doses compared with a standard treatment plan.
Gears with 2016 and 2017
In the News
Year in Review: The Science and Technology that Shaped Cancer Care in 2017

As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.
Aviv Regev of the Broad Institute and the Massachusetts Institute of Technology
Announcement
Three Investigators Named Winners of the 2017 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising early-career investigators.
Sloan Kettering Institute Director Joan Massagué with laboratory member Karuna Ganesh
In the Lab
When Cancer Spreads: Research Focuses on Better Ways to Treat Metastasis

MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.
MSK pathologist Christine Iacobuzio-Donahue
Q&A
What Evolution Can Tell Us about How Cancer Spreads

Meet Christine Iacobuzio-Donahue, a physician-scientist who studies cancer metastasis and is collaborating on genetics research with scientists at the American Museum of Natural History.
A microscopic view of genetically engineered mouse tumor and a human FL-HCC tumor
In the Lab
With Help of CRISPR, Scientists Unravel the Cause of a Rare Liver Cancer

A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.
Zeda Zhang
Honors
GSK Student Wins NCI Award to Pursue Innovative Prostate Cancer Research

Zeda Zhang was recently awarded the Predoctoral to Postdoctoral Fellow Transition Award from the National Cancer Institute (NCI).
elderly patient and caregiver
Feature
9 Tips for Caregivers: How to Help a Loved One with Cancer

Hear from members of the MSK community who have cared for a loved one with cancer.